Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Procainamide;

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 80190 refers to a laboratory test specifically designed to measure the levels of procainamide in the blood. Procainamide is a medication classified as a cardiac antidysrhythmic agent, which means it is used to manage and treat irregular heartbeats, particularly ventricular tachycardia. This drug works by blocking abnormal electrical impulses in the heart, thereby helping to restore a normal rhythm. The test may also include the measurement of procainamide metabolites, notably n-acetyl procainamide, which can provide additional insights into the drug's efficacy and safety in the patient’s system. Regular monitoring of procainamide levels is crucial, as it helps healthcare providers ensure that the drug concentration remains within a therapeutic range, minimizing the risk of toxicity and adverse effects. It is important to note that procainamide can lead to the formation of antinuclear antibodies, which may present symptoms similar to systemic lupus erythematosus, a condition that can affect various systems in the body. The blood sample required for this test is obtained through a venipuncture, a procedure that is separately reportable. The analysis of the blood serum is conducted using a technique known as fluorescence polarization immunoassay, which is a sensitive method for detecting and quantifying drug levels in the bloodstream.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procainamide blood test (CPT® Code 80190) is indicated for the following conditions:

  • Monitoring Therapeutic Levels This test is performed to monitor the blood concentration levels of procainamide to ensure they remain within the therapeutic range, which is essential for effective treatment and to avoid toxicity.
  • Assessment of Drug Efficacy It is used to evaluate the effectiveness of procainamide therapy in patients diagnosed with ventricular tachycardia, ensuring that the medication is achieving the desired therapeutic effect.
  • Detection of Adverse Effects The test may also be indicated in cases where patients exhibit symptoms that could suggest adverse reactions to procainamide, such as the formation of antinuclear antibodies.

2. Procedure

The procedure for obtaining a procainamide blood test involves several key steps:

  • Step 1: Patient Preparation Prior to the blood draw, the patient may be instructed to avoid certain medications or substances that could interfere with the test results. It is essential to ensure that the patient is adequately informed about the procedure and any necessary preparations.
  • Step 2: Venipuncture A qualified healthcare professional performs a venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to collect the required volume of blood. The site is cleaned with an antiseptic to minimize the risk of infection.
  • Step 3: Sample Handling Once the blood sample is collected, it is properly labeled and handled according to laboratory protocols to ensure accurate testing. The sample is then sent to the laboratory for analysis.
  • Step 4: Laboratory Analysis In the laboratory, the blood serum is tested using fluorescence polarization immunoassay, a method that allows for the precise measurement of procainamide and its metabolites in the serum. This technique utilizes the principles of fluorescence to quantify the drug levels effectively.

3. Post-Procedure

After the blood sample has been collected, there are generally no specific post-procedure care requirements for the patient. However, patients may be advised to apply pressure to the venipuncture site to minimize bruising and bleeding. Results from the procainamide test are typically available within a few days, and healthcare providers will review the findings to determine if any adjustments to the patient's medication regimen are necessary based on the procainamide levels measured. It is important for patients to follow up with their healthcare provider to discuss the results and any potential implications for their treatment plan.

Short Descr ASSAY OF PROCAINAMIDE
Medium Descr DRUG SCREEN QUANTITATIVE PROCAINAMIDE
Long Descr Procainamide;
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 2
CCS Clinical Classification 235 - Other Laboratory
Date
Action
Notes
2013-01-01 Changed Medium description changed per AMA 2013 corrections document dated January 25, 2013.
2010-01-01 Changed Code description changed.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"